There’s nothing quite like a comprehensive report on the growth of the mHealth market to really get the blood pumping.
This week, “The Mobile Healthcare (mHealth) Bible: 2014 – 2020” was published, revealing a multitude of opportunities for the pharmaceutical industry thanks to the emerging technologies of our time.
Despite barriers relating to regulation, patient acceptance and privacy concerns, research estimates further growth at a CAGR of nearly 40% over the next 6 years.
Other key findings of the report include:
- The widespread availability of high speed connectivity has opened up considerable opportunities for advanced mHealth applications such as remote video consultation
- Besides video applications, mobile network operators are also eyeing on other latency & bandwidth sensitive mHealth applications to capitalize on their recent LTE infrastructure upgrades. For example London’s Air Ambulance uses EE’s LTE network for navigational support
- mHealth offers a multitude to opportunities to the pharmaceutical industry ranging from R&D activities to securing the supply chain and, in the battle against counterfeit drugs
- mHealth has the potential to dramatically reduce the costs of healthcare operations, while improving the quality of healthcare. SNS Research estimates that by the end of 2014, mHealth could represent up to $250 Billion in annual healthcare cost savings worldwide
To learn more or to obtain a copy of the report, click here.